Hong Wang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Platelet Rich Plasma

Top Venues

Medicinal research reviews

Nature communications

Evidence-based complementary and alternative medicine : eCAM

China Pharmaceutical University

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University Jul 01 2019

China

Associate Professor

China Pharmaceutical University Jul 01 2015 - Jun 30 2019

China

Postdoctor

Education History

China Pharmaceutical University Sep 01 2010 - Jun 30 2015

China

PHD

Chongqing Medical University Sep 01 2006 - Jun 30 2010

China

BSC :: School of Pharmacy

Publications

Kang Wang, Yuecan Zhang, Guangji Wang, Hai-Ping Hao, Hong Wang
FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid. Medicinal research reviews (2023)
Min Zhao, Qiufang Chen, Hong Wang, Wanfeng Xu, Jiayong Yang, Li-Juan Cao
Comparison of Protective Effects of Shenmai Injections Produced by Medicinal Materials from Different Origins on Cardiomyocytes. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Jiyu Zhou, Shuang Cui, Qingxian He, Yitong Guo, Xiaojie Pan, Pengfei Zhang, Ningning Huang, Chaoliang Ge, Guang-Ji Wang, Frank J Gonzalez, Hong Wang, Hai-Ping Hao
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nature communications 11 (1) (2020)